| Filed On | Filing |
|---|---|
| 05 Feb 2026 |
Form 3: Jeddi Iman, SVP & GM da Vinci Platforms &
Holds 26,649 shares of Common Stock |
| 05 Feb 2026 | Form 3: Wadors Patricia L, See Remarks |
| 25 Apr 2024 |
Form 3: Chew Lewis, Director
Holds 44 shares of Common Stock |
| 08 Feb 2024 |
Form 3: Miller Brian Edward, EVP & Chief Digital Officer
Holds 8,952 shares of Common Stock |
| 05 Feb 2024 |
Form 3: Brosius Mark, See Remarks
Holds 487 shares of Common Stock |
| 03 Nov 2023 |
Form 3: Kolli Sreelakshmi, Director
No securities owned |
| 02 Feb 2023 |
Form 3: DiMartino Michele, See Remarks
Holds 397 shares of Common Stock |
| 04 Oct 2022 |
Form 3: Loeb Gary, General Counsel and CCO
No securities owned |
| 10 Jan 2022 |
Form 3: Widman Fredrik, See Remarks
Holds 1,104 shares of Common Stock |
| 07 Jan 2022 |
Form 3: Charlton Henry L, SVP & Chief Commercial Officer
Holds 13,044 shares of Common Stock |
| 23 Apr 2021 |
Form 3: Reed Monica P, Director
No securities owned |
| 24 Apr 2020 |
Form 3: Beery Joseph C, Director
No securities owned |
| 10 Apr 2020 |
Form 3: DeSantis Robert, Executive VP & GM IA&E
Holds 4,381 shares of Common Stock |
| 01 Aug 2019 |
Form 3: Ladd Amy L, Director
No securities owned |
| 06 Feb 2019 |
Form 3: Andersen Reiter Kara, Sr VP General Counsel & CCO
Holds 3,309 shares of Common Stock |
| 01 Aug 2018 |
Form 3: Kania Don R, Director
No securities owned |
| 21 Apr 2017 |
Form 3: Nachtsheim Jami K, Director
No securities owned |
| 28 Jan 2016 |
Form 3: Leonard Keith R, Director
No securities owned |
| 27 Jul 2015 |
Form 3: Friedman Michael A, Director
No securities owned |
| 06 Feb 2015 |
Form 3: Myriam Curet, SVP & Chief Medical Officer
Holds 63 shares of Common Stock |
Loading...